Our Pricing

Buy Mounjaro Injections Online UK - From £135.00

When you buy Mounjaro injections online UK through Cured Pharmacy, you receive genuine UK-licensed tirzepatide pens from £135.00, with transparent upfront pricing and a free clinical consultation completed in under three minutes. Our UK-registered prescribers assess your suitability, and once approved, your medication is dispensed discreetly to your door by our GPhC-registered pharmacy team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

How Mounjaro (Tirzepatide) Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, which enhances insulin secretion, reduces glucagon levels, and slows gastric emptying to produce a sustained feeling of fullness [1].

In the SURMOUNT-1 clinical trial, participants receiving the 15mg tirzepatide dose achieved an average body weight reduction of 22.5% over 72 weeks, compared to 2.4% in the placebo group [1]. This dual-action mechanism explains why tirzepatide consistently demonstrates superior weight loss outcomes compared to single-receptor agonists in head-to-head studies [2].

The medication is administered once weekly via a pre-filled KwikPen injector, with doses typically starting at 2.5mg and gradually increasing every four weeks to minimise gastrointestinal side effects. Your UK prescriber will determine the appropriate maintenance dose based on your response and tolerability, with most patients reaching effective doses between 10mg and 15mg weekly [3].

Mounjaro vs Wegovy: Comparing Weight Loss Injections

Both Mounjaro and Wegovy are MHRA-licensed injectable treatments for weight management, but they operate through different mechanisms and demonstrate distinct clinical profiles. Wegovy contains semaglutide, a GLP-1 receptor agonist that has been available in the UK since 2023, whilst Mounjaro's tirzepatide represents the newer dual GIP/GLP-1 approach approved more recently [2].

Head-to-head comparisons in the SURPASS-2 trial showed that tirzepatide produced greater average weight loss than semaglutide across all dose levels, with the 15mg tirzepatide group achieving approximately 5.5kg more weight reduction than the 1mg semaglutide group over 40 weeks [2]. However, both medications share similar side effect profiles, predominantly gastrointestinal symptoms such as nausea and diarrhoea, which typically diminish after the first few weeks of treatment [4].

The choice between these treatments depends on individual factors including your medical history, previous treatment responses, and prescriber assessment. Some patients may respond better to one mechanism over another, and cost considerations may also influence the decision when both options are clinically appropriate.

Which Treatment Is Right for You?

Your UK prescriber will evaluate several factors during your consultation, including your BMI, weight loss goals, medical history, current medications, and any contraindications. Patients with a history of thyroid conditions, pancreatitis, or severe gastrointestinal disease may not be suitable candidates for GLP-1 or dual-agonist therapies [3]. The prescriber will recommend the most appropriate treatment based on clinical guidelines and your individual circumstances, with the option to switch medications if your initial choice doesn't produce the desired results or causes intolerable side effects.

Mounjaro Dosing Schedule and What to Expect

The standard Mounjaro titration schedule begins with a 2.5mg weekly injection for the first four weeks, allowing your body to adjust to the medication whilst minimising side effects. The dose then increases to 5mg weekly for another four weeks, followed by further increases to 7.5mg, 10mg, 12.5mg, and finally 15mg, with each step lasting four weeks [3].

This gradual dose escalation is crucial for tolerability — patients who increase doses too quickly experience significantly higher rates of nausea and vomiting. Most individuals notice appetite reduction within the first week of treatment, with progressive weight loss becoming evident from week four onwards. The maximum therapeutic effect typically occurs between 20 and 36 weeks of treatment, though weight loss continues at a slower rate beyond this point [1].

Each KwikPen contains four weekly doses at your prescribed strength, and you'll inject into your abdomen, thigh, or upper arm on the same day each week. The injection process takes less than 30 seconds, and most patients report minimal discomfort. Your prescriber will provide detailed administration instructions, and you can rotate injection sites to prevent lipohypertrophy or skin irritation.

Managing Side Effects During Treatment

The most common side effects include nausea (reported by 20-30% of patients), diarrhoea, constipation, and reduced appetite [4]. These symptoms are usually mild to moderate and resolve within two to four weeks as your body adapts. Eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated can significantly reduce gastrointestinal discomfort. If side effects persist or worsen, contact your prescriber — they may recommend slowing the dose escalation or temporarily reducing your dose before increasing again.

How to Buy Mounjaro Injections Online UK Through Cured Pharmacy

Purchasing Mounjaro through Cured Pharmacy begins with a free online consultation that takes under three minutes to complete. You'll answer questions about your medical history, current medications, weight loss goals, and any previous experience with weight management treatments. This information is reviewed by a UK-registered prescriber who determines whether Mounjaro is clinically appropriate for you.

If approved, your prescription is sent electronically to our GPhC-registered pharmacy (registration number 9012511), where our team dispenses your medication in discreet, unmarked packaging. We offer next-day delivery across the UK, and you'll receive tracking information once your order is dispatched. The entire process from consultation to delivery typically takes 24-48 hours for patients approved on first assessment.

All Mounjaro pens supplied by Cured Pharmacy are UK-licensed products sourced through legitimate pharmaceutical supply chains, ensuring you receive genuine medication with full traceability. We never supply unlicensed imports or compounded alternatives. Your prescription remains valid for ongoing treatment, with automatic reminders when it's time to reorder, though you'll need periodic prescriber reviews to ensure the treatment remains appropriate.

Transparent Pricing with No Hidden Fees

At Cured Pharmacy, Mounjaro pricing starts from £135.00, with the exact cost depending on your prescribed dose. Unlike some providers, we display prices upfront before you complete your consultation, so you know the full cost before committing. This price includes the medication, prescriber consultation, and standard delivery — there are no hidden consultation fees or subscription charges added at checkout.

Who Can Use Mounjaro for Weight Loss?

Mounjaro is licensed in the UK for adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related health condition such as type 2 diabetes, hypertension, or obstructive sleep apnoea [5]. The medication is intended for use alongside a reduced-calorie diet and increased physical activity, not as a standalone solution.

You may not be suitable for Mounjaro if you have a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe kidney disease, diabetic retinopathy complications, or a history of pancreatitis [3]. Pregnant or breastfeeding individuals should not use tirzepatide, and women of childbearing potential should use effective contraception during treatment, as the medication's effects on pregnancy are not fully established.

Your prescriber will also review potential drug interactions, particularly with insulin or sulfonylureas, which may require dose adjustments to prevent hypoglycaemia. Mounjaro slows gastric emptying, which can affect the absorption of oral medications, so timing of other medicines may need adjustment under prescriber guidance [4].

Alternative Weight Loss Treatments Available at Cured Pharmacy

If Mounjaro isn't suitable or you're exploring other options, Cured Pharmacy offers a comprehensive range of MHRA-licensed weight management treatments. Wegovy (semaglutide) provides a proven GLP-1 receptor agonist alternative with once-weekly injections, whilst Saxenda (liraglutide) offers a daily injection option for patients who prefer more frequent, lower-dose administration.

For patients seeking non-injectable options, Orlistat and Xenical work by blocking approximately 30% of dietary fat absorption in the intestines, producing modest weight loss when combined with a low-fat diet [6]. These medications suit individuals who prefer oral capsules or have contraindications to GLP-1 therapies. Alli offers a lower-dose orlistat option available without prescription for those with a BMI of 28 or above.

Your prescriber can discuss which treatment aligns best with your medical profile, lifestyle preferences, and weight loss goals. Many patients try multiple options over time, and switching between treatments is common if initial choices don't produce expected results or cause problematic side effects. All prescription treatments require clinical assessment and ongoing monitoring to ensure safe, effective use.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
3. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines.org.uk. https://www.medicines.org.uk/emc/product/14553
4. Dahl, D., Onishi, Y., Norwood, P., et al. (2022). Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial. JAMA, 327(6), 534–545. https://doi.org/10.1001/jama.2022.0078
5. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating obesity. NICE Technology Appraisal Guidance. https://www.nice.org.uk/guidance/indevelopment/gid-ta11235
6. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and lifestyle changes.